LI-COR, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 1971-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.licor.com
Open-label Study to Evaluate Nerindocianine as a Surgical Aid in Ureter Delineation During Minimally Invasive Surgery
Phase 2
Withdrawn
- Conditions
- Intraoperative Ureter Injury
- Interventions
- Drug: Nerindocianine for injection
- First Posted Date
- 2020-11-19
- Last Posted Date
- 2021-07-02
- Lead Sponsor
- Li-Cor, Inc.
- Registration Number
- NCT04636567
- Locations
- 🇺🇸
Cleveland Clinic Florida, Weston, Florida, United States
🇺🇸Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States
Dose-escalation Study of a Contrast Agent for Delineation of Urological Anatomy in Minimally Invasive Surgery
Phase 1
Completed
- Conditions
- Intraoperative Ureter Injury
- Interventions
- Drug: Nerindocianine for Injection
- First Posted Date
- 2017-04-10
- Last Posted Date
- 2019-11-26
- Lead Sponsor
- Li-Cor, Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT03106038
- Locations
- 🇺🇸
UAB Women & Infants Center, Birmingham, Alabama, United States
© Copyright 2025. All Rights Reserved by MedPath